Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo bay cohort project VIII

American Journal of Tropical Medicine and Hygiene

Volumn 65, Issue 2, 2001, Pages 100-107

  Udhayakumar, V ^a   Kariuki, S ^a   Kolczack, M ^a   Girma, M ^a   Roberts, J M ^a   Oloo, A J ^a   Nahlen, B L ^a   Lal, A A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; APICAL MEMBRANE ANTIGEN 1; EPITOPE; MYCOBACTERIUM ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ANTIBODY RESPONSE; APICAL MEMBRANE; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; HUMAN; IMMUNE RESPONSE; KENYA; LONGITUDINAL STUDY; MALARIA FALCIPARUM; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; T LYMPHOCYTE;

MYCOBACTERIUM; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0034879657     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2001.65.100     Document Type: Article

References (23)

1. Preventing merozoite invasion of erythrocytes
2. Integral membrane protein located in the apical complex of Plasmodium falciparum
3. Plasmodium falciparum: Two antigens of similar size are located in different compartments of the rhoptry
4. A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium
5. Rat monclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi
6. The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes
7. Analysis of variation in Pf83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium falciparum
8. Genetic conservation of the Plasmodium falciparum apical membrane antigen-1 (AMA-1)
9. Vaccination trial in rhesus monkey with minor, invariant, Plasmodium knowlesi
10. Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile
11. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes
12. Immunization with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi
13. High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1
14. Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria
15. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population
16. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children
17. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1
18. Natural antibody responses against the non-repeat sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein
19. Longitudinal data analysis for discrete and continuous outcomes
20. A longitudinal study of naturally acquired cellular and humoral immune response to a merozoite protein (MSP-1) of Plasmodium falciparum in an area of seasonal malaria transmission
21. Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short lived
22. Characterization of naturally acquired antibody responses to a recombinant fragment from the N-terminus of Plasmodium falciparum glycoprotein 195